COLISTIMETHATE

COLISTIMETHATE was reported 1619 times

COLISTIMETHATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PULMONARY BULLECTOMY 1 0.1667
1 TOXIC CATARACT 1 0.1429
2 TRACHEAL NECROSIS 1 0.1111
3 RHINOTRACHEITIS 1 0.0909
4 MYCOBACTERIAL DISEASE CARRIER 1 0.0625
5 PSEUDO-BARTTER SYNDROME 6 0.0577
6 ALCALIGENES INFECTION 1 0.0417
7 CYSTIC FIBROSIS GASTROINTESTINAL DISEASE 1 0.0400
8 VAGINAL CELLULITIS 1 0.0278
9 PHYSICAL EXAMINATION 1 0.0278
10 FAECAL ELASTASE CONCENTRATION DECREASED 1 0.0263
11 RENAL IMPAIRMENT NEONATAL 2 0.0198
12 WOUND CELLULITIS 1 0.0192
13 MEDICAL DEVICE SITE CELLULITIS 1 0.0172
14 ACHROMOBACTER INFECTION 2 0.0167
15 LUNG ASSIST DEVICE THERAPY 1 0.0161
16 CYSTIC FIBROSIS LUNG 2 0.0156
17 NEUROMUSCULAR BLOCKADE 3 0.0134
18 CATHETERISATION VENOUS 1 0.0122
19 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 56 0.0103
20 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 9 0.0101
21 CLOSTRIDIUM DIFFICILE SEPSIS 1 0.0089
22 HYPNOPOMPIC HALLUCINATION 1 0.0081
23 STENOTROPHOMONAS TEST POSITIVE 1 0.0075
24 CYSTIC FIBROSIS 37 0.0067
25 RESPIRATORY FUME INHALATION DISORDER 2 0.0065
26 RESPIRATORY PARALYSIS 1 0.0063
27 BILE ACIDS INCREASED 1 0.0056
28 CELLULITIS GANGRENOUS 1 0.0051
29 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
30 PERIORBITAL DISORDER 1 0.0049
31 PARALYSIS FLACCID 1 0.0046
32 MENINGITIS CHEMICAL 1 0.0045
33 CARDIAC SARCOIDOSIS 1 0.0043
34 PULMONARY RESECTION 1 0.0040
35 PHARYNGITIS BACTERIAL 1 0.0039
36 BACTERIAL ENDOPHTHALMITIS 1 0.0038
37 MORAXELLA INFECTION 1 0.0036
38 FUNGAL SEPSIS 3 0.0036
39 SHUNT STENOSIS 1 0.0036
40 ORTHOSIS USER 1 0.0036
41 BLOOD OESTROGEN INCREASED 2 0.0034
42 EYE ABSCESS 1 0.0033
43 PNEUMONIA PSEUDOMONAL 5 0.0033
44 INFECTIVE EXACERBATION OF BRONCHIECTASIS 1 0.0033
45 CNS VENTRICULITIS 1 0.0031
46 DISTAL INTESTINAL OBSTRUCTION SYNDROME 1 0.0030
47 PNEUMONIA ESCHERICHIA 1 0.0029
48 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 1 0.0029
49 SPORTS INJURY 1 0.0029
50 SINUSITIS BACTERIAL 3 0.0028
51 LUNG TRANSPLANT 10 0.0028
52 DIABETIC KETOSIS 1 0.0026
53 LOWER RESPIRATORY TRACT INFECTION FUNGAL 1 0.0026
54 TRACHEOMALACIA 1 0.0025
55 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 1 0.0025
56 SKIN NODULE 1 0.0025
57 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 1 0.0023
58 CORONA VIRUS INFECTION 1 0.0023
59 CANDIDA SEPSIS 2 0.0022
60 PULMONARY EOSINOPHILIA 1 0.0022
61 CENTRAL VENOUS CATHETER REMOVAL 1 0.0021
62 PULMONARY FUNCTION TEST DECREASED 9 0.0021
63 INFECTIVE ANEURYSM 1 0.0020
64 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0020
65 BLADDER OBSTRUCTION 1 0.0019
66 KELOID SCAR 1 0.0019
67 MANUFACTURING PRODUCT SHIPPING ISSUE 1 0.0018
68 MEDIASTINITIS 1 0.0017
69 INCREASED VISCOSITY OF BRONCHIAL SECRETION 1 0.0016
70 NASAL SEPTUM PERFORATION 1 0.0015
71 PATHOGEN RESISTANCE 14 0.0015
72 PNEUMOTHORAX SPONTANEOUS 1 0.0015
73 DEATH NEONATAL 2 0.0014
74 GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
75 DIFFERENTIATION SYNDROME 1 0.0014
76 SERRATIA INFECTION 1 0.0013
77 BRONCHITIS BACTERIAL 1 0.0013
78 CAUDA EQUINA SYNDROME 1 0.0013
79 TRACHEOBRONCHITIS 1 0.0013
80 METAPNEUMOVIRUS INFECTION 1 0.0013
81 RESPIRATORY RATE DECREASED 4 0.0013
82 SUPERINFECTION BACTERIAL 1 0.0013
83 PSEUDOMONAS TEST POSITIVE 1 0.0012
84 SOCIAL PROBLEM 5 0.0012
85 SEPTIC EMBOLUS 1 0.0012
86 PSEUDOMONAL BACTERAEMIA 1 0.0012
87 CRANIOFACIAL FRACTURE 1 0.0012
88 ALLERGIC SINUSITIS 1 0.0012
89 OESOPHAGEAL OBSTRUCTION 1 0.0012
90 PRODUCT RECONSTITUTION QUALITY ISSUE 1 0.0011
91 CATARRH 1 0.0011
92 CATHETER SITE SWELLING 1 0.0011
93 PSEUDOMONAS INFECTION 9 0.0010
94 INFUSION SITE NODULE 1 0.0010
95 PROSTATE INFECTION 1 0.0010
96 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
97 ACQUIRED HAEMOPHILIA 1 0.0010
98 DILATED CARDIOMYOPATHY 1 0.0010
99 ALVEOLITIS ALLERGIC 1 0.0010
100 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
101 INNER EAR DISORDER 1 0.0009
102 ACINETOBACTER INFECTION 1 0.0009
103 NEPHROPATHY TOXIC 10 0.0009
104 BLOOD FIBRINOGEN DECREASED 1 0.0009
105 DISEASE COMPLICATION 4 0.0009
106 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 1 0.0008
107 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 1 0.0008
108 URINARY TRACT INFECTION BACTERIAL 2 0.0008
109 SEROMA 1 0.0008
110 BRONCHIAL SECRETION RETENTION 1 0.0008
111 INCREASED BRONCHIAL SECRETION 2 0.0008
112 MUCORMYCOSIS 2 0.0008
113 PREMENSTRUAL SYNDROME 1 0.0007
114 FORCED EXPIRATORY VOLUME DECREASED 2 0.0007
115 NEUROTOXICITY 12 0.0007
116 SLEEP PARALYSIS 1 0.0007
117 PORTAL HYPERTENSION 2 0.0006
118 GASTROSTOMY 1 0.0006
119 PULMONARY FUNCTION TEST ABNORMAL 1 0.0006
120 MULTI-ORGAN FAILURE 11 0.0006
121 PHARYNGEAL PARAESTHESIA 1 0.0006
122 AORTIC VALVE DISEASE 1 0.0006
123 INFUSION SITE HAEMORRHAGE 2 0.0006
124 QUADRIPARESIS 1 0.0006
125 BRONCHIECTASIS 4 0.0006
126 SPINAL CORD INJURY 1 0.0006
127 EMOTIONAL POVERTY 1 0.0006
128 DRUG SCREEN NEGATIVE 1 0.0006
129 MITRAL VALVE DISEASE 1 0.0006
130 NEUTROPENIC SEPSIS 4 0.0006
131 PNEUMONIA KLEBSIELLA 1 0.0005
132 CHRONIC SINUSITIS 2 0.0005
133 BONE MARROW TRANSPLANT 1 0.0005
134 BILE DUCT OBSTRUCTION 1 0.0005
135 ARTERIAL DISORDER 1 0.0005
136 TRAUMATIC LUNG INJURY 1 0.0005
137 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
138 NASAL SEPTUM DEVIATION 1 0.0005
139 OCCULT BLOOD POSITIVE 1 0.0005
140 CHOLANGITIS SCLEROSING 1 0.0005
141 QUADRIPLEGIA 1 0.0005
142 INFUSION SITE EXTRAVASATION 3 0.0005
143 THROAT CANCER 2 0.0005
144 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 1 0.0005
145 HAEMOPTYSIS 13 0.0005
146 INFUSION SITE BRUISING 1 0.0005
147 SPUTUM INCREASED 1 0.0005
148 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
149 FEAR OF DEATH 1 0.0004
150 PNEUMOTHORAX 7 0.0004
151 RESPIRATION ABNORMAL 3 0.0004
152 NEUROLOGICAL DECOMPENSATION 1 0.0004
153 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
154 DISTURBANCE IN SOCIAL BEHAVIOUR 1 0.0004
155 GASTROINTESTINAL OBSTRUCTION 1 0.0004
156 TRANSPLANT FAILURE 1 0.0004
157 THERAPY CHANGE 4 0.0004
158 BREATH SOUNDS ABNORMAL 2 0.0004
159 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
160 GASTROINTESTINAL TUBE INSERTION 1 0.0004
161 HYPERPARATHYROIDISM SECONDARY 1 0.0004
162 NOCARDIOSIS 1 0.0004
163 APNOEA 3 0.0004
164 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
165 AREFLEXIA 1 0.0004
166 STEATORRHOEA 1 0.0004
167 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
168 HAEMODIALYSIS 3 0.0004
169 RESPIRATORY SYMPTOM 1 0.0004
170 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
171 ADENOVIRUS INFECTION 1 0.0003
172 THORACIC VERTEBRAL FRACTURE 1 0.0003
173 BACTERAEMIA 4 0.0003
174 ATAXIA 4 0.0003
175 ACNE CYSTIC 1 0.0003
176 HYPOAESTHESIA ORAL 5 0.0003
177 PNEUMONIA BACTERIAL 3 0.0003
178 LUNG INFECTION 5 0.0003
179 PNEUMONIA VIRAL 1 0.0003
180 ASPERGILLUS INFECTION 2 0.0003
181 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1 0.0003
182 BLOOD UREA INCREASED 5 0.0003
183 WOUND DEHISCENCE 1 0.0003
184 DEPRESSIVE SYMPTOM 1 0.0003
185 BACTERIAL INFECTION 5 0.0003
186 PARANASAL SINUS DISCOMFORT 1 0.0003
187 PRODUCT STORAGE ISSUE 1 0.0003
188 REHABILITATION THERAPY 1 0.0003
189 RHINOVIRUS INFECTION 1 0.0003
190 SPINAL CORD COMPRESSION 1 0.0003
191 PULMONARY HAEMORRHAGE 2 0.0003
192 MULTIPLE ALLERGIES 2 0.0003
193 SKIN ODOUR ABNORMAL 1 0.0003
194 PNEUMONIA FUNGAL 1 0.0003
195 SINUS DISORDER 5 0.0003
196 BLOOD ALBUMIN DECREASED 2 0.0003
197 AZOTAEMIA 1 0.0003
198 OBSTRUCTION 1 0.0003
199 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
200 MYOPATHY 2 0.0002
201 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
202 CATHETERISATION CARDIAC 1 0.0002
203 RHINITIS ALLERGIC 1 0.0002
204 VASCULAR DEVICE INFECTION 1 0.0002
205 CHRONIC MYELOID LEUKAEMIA 1 0.0002
206 NEPHROGENIC ANAEMIA 1 0.0002
207 PRODUCT DISTRIBUTION ISSUE 2 0.0002
208 VAGINAL INFECTION 1 0.0002
209 DIALYSIS 3 0.0002
210 SPUTUM DISCOLOURED 2 0.0002
211 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
212 GESTATIONAL DIABETES 1 0.0002
213 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
214 PARAESTHESIA ORAL 3 0.0002
215 HORMONE LEVEL ABNORMAL 1 0.0002
216 RENAL TUBULAR NECROSIS 2 0.0002
217 ENCEPHALOPATHY 5 0.0002
218 STAPHYLOCOCCAL SEPSIS 1 0.0002
219 HYPERVOLAEMIA 1 0.0002
220 DIABETIC NEUROPATHY 1 0.0002
221 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
222 TOXIC ENCEPHALOPATHY 1 0.0002
223 ENDOCARDITIS 1 0.0002
224 POOR VENOUS ACCESS 2 0.0002
225 HYPERBILIRUBINAEMIA 2 0.0002
226 SKIN NECROSIS 1 0.0002
227 MALABSORPTION 1 0.0002
228 PARTIAL SEIZURES 1 0.0002
229 RENAL FAILURE ACUTE 8 0.0002
230 COMPRESSION FRACTURE 1 0.0002
231 SEPTIC SHOCK 8 0.0002
232 PULMONARY THROMBOSIS 2 0.0002
233 NONSPECIFIC REACTION 1 0.0002
234 HOSPITALISATION 28 0.0002
235 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
236 GASTRIC ULCER HAEMORRHAGE 1 0.0002
237 STREPTOCOCCAL INFECTION 1 0.0002
238 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
239 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
240 EXERCISE TOLERANCE DECREASED 1 0.0002
241 HYPOVOLAEMIA 1 0.0002
242 DECREASED INTEREST 1 0.0002
243 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
244 MYOCLONUS 2 0.0002
245 PRODUCTIVE COUGH 8 0.0002
246 PROTHROMBIN TIME PROLONGED 1 0.0002
247 INFECTION 24 0.0002
248 PNEUMONIA ASPIRATION 4 0.0002
249 INFUSION SITE SWELLING 1 0.0002
250 RESPIRATORY TRACT INFECTION 4 0.0002
251 TERMINAL STATE 1 0.0001
252 BLOOD BILIRUBIN INCREASED 4 0.0001
253 ONYCHOCLASIS 1 0.0001
254 MENTAL STATUS CHANGES 4 0.0001
255 LARGE INTESTINE PERFORATION 1 0.0001
256 SEASONAL ALLERGY 2 0.0001
257 BRONCHOSPASM 2 0.0001
258 BLOOD CREATININE INCREASED 9 0.0001
259 FLUID OVERLOAD 2 0.0001
260 MOUTH HAEMORRHAGE 1 0.0001
261 CEREBRAL DISORDER 1 0.0001
262 WHEEZING 8 0.0001
263 BREAST TENDERNESS 1 0.0001
264 PAROSMIA 1 0.0001
265 INSURANCE ISSUE 2 0.0001
266 RENAL FAILURE CHRONIC 1 0.0001
267 HYPOALBUMINAEMIA 1 0.0001
268 SLEEP DISORDER 9 0.0001
269 AFFECTIVE DISORDER 1 0.0001
270 RESPIRATORY TRACT CONGESTION 2 0.0001
271 RHINITIS 1 0.0001
272 RESPIRATORY FAILURE 9 0.0001
273 ESCHERICHIA INFECTION 1 0.0001
274 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
275 MENSTRUAL DISORDER 1 0.0001
276 VIRAL INFECTION 4 0.0001
277 CANDIDA INFECTION 2 0.0001
278 DRUG RESISTANCE 3 0.0001
279 CARDIAC OPERATION 1 0.0001
280 UNRESPONSIVE TO STIMULI 3 0.0001
281 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
282 IMMUNOSUPPRESSION 1 0.0001
283 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
284 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
285 RESPIRATORY RATE INCREASED 1 0.0001
286 GASTROINTESTINAL INFECTION 1 0.0001
287 HEAVY MENSTRUAL BLEEDING 1 0.0001
288 ACUTE KIDNEY INJURY 17 0.0001
289 THROAT TIGHTNESS 3 0.0001
290 HIDRADENITIS 1 0.0001
291 RESPIRATORY DISTRESS 3 0.0001
292 PNEUMONIA 35 0.0001
293 ERYTHEMA MULTIFORME 1 0.0001
294 FLANK PAIN 1 0.0001
295 SPINAL DISORDER 1 0.0001
296 INCREASED APPETITE 2 0.0001
297 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
298 CHOLESTASIS 2 0.0001
299 ACUTE RESPIRATORY FAILURE 2 0.0001
300 DIZZINESS POSTURAL 1 0.0001
301 ASCITES 3 0.0001
302 LUNG DISORDER 5 0.0001
303 HOSPICE CARE 1 0.0001
304 LIGAMENT SPRAIN 1 0.0001
305 BLADDER DISORDER 1 0.0001
306 RESPIRATORY DISORDER 3 0.0001
307 BRAIN INJURY 1 0.0001
308 SINUSITIS 10 0.0001
309 INITIAL INSOMNIA 1 0.0001
310 WEIGHT FLUCTUATION 1 0.0001
311 PRODUCT ODOUR ABNORMAL 1 0.0001
312 JOINT DISLOCATION 1 0.0001
313 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
314 OFF LABEL USE 82 0.0001
315 BODY HEIGHT DECREASED 1 0.0001
316 PRODUCT DISPENSING ERROR 2 0.0001
317 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
318 PRODUCT USE ISSUE 17 0.0001
319 FOOT DEFORMITY 1 0.0001
320 LIP SWELLING 3 0.0001
321 SEPSIS 10 0.0001
322 MALNUTRITION 1 0.0001
323 RASH PAPULAR 2 0.0001
324 PANCREATITIS ACUTE 2 0.0001
325 MYOCARDIAL ISCHAEMIA 1 0.0001
326 DERMATITIS CONTACT 1 0.0001
327 NEPHROLITHIASIS 4 0.0001
328 SHOCK 2 0.0001
329 RENAL DISORDER 4 0.0001
330 HYPERKALAEMIA 3 0.0001
331 RENAL FAILURE 11 0.0001
332 ILL-DEFINED DISORDER 5 0.0001
333 CONDITION AGGRAVATED 25 0.0001
334 NO THERAPEUTIC RESPONSE 1 0.0001
335 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
336 SMALL INTESTINAL OBSTRUCTION 1 0.0001
337 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
338 SECRETION DISCHARGE 1 0.0001
339 BRAIN OEDEMA 1 0.0001
340 INFUSION SITE PAIN 1 0.0001
341 ORAL CANDIDIASIS 1 0.0001
342 PULMONARY CONGESTION 1 0.0001
343 ADVERSE REACTION 1 0.0001
344 EYE HAEMORRHAGE 1 0.0001
345 SINUS CONGESTION 1 0.0001
346 PRODUCT TASTE ABNORMAL 1 0.0001
347 TACHYPNOEA 1 0.0001
348 SKIN LESION 2 0.0001
349 HYPOMAGNESAEMIA 1 0.0001
350 HEPATOCELLULAR INJURY 1 0.0001
351 SUBDURAL HAEMATOMA 1 0.0001
352 PARALYSIS 1 0.0001
353 IMPAIRED QUALITY OF LIFE 1 0.0001
354 ILLNESS 7 0.0001
355 COUGH 19 0.0001
356 PULMONARY MASS 1 0.0001
357 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
358 PLEURAL EFFUSION 4 0.0001
359 EMOTIONAL DISORDER 2 0.0001
360 MUSCULOSKELETAL CHEST PAIN 1 0.0001
361 TENDONITIS 1 0.0001
362 BRAIN FOG 1 0.0001
363 PRODUCT USE COMPLAINT 1 0.0001
364 HEAD INJURY 2 0.0001
365 SCIATICA 1 0.0001
366 DYSPNOEA 35 0.0001
367 SEIZURE 7 0.0001
368 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
369 INFUSION RELATED REACTION 4 0.0001
370 FLUID RETENTION 3 0.0001
371 CHEST DISCOMFORT 6 0.0001
372 THERAPY CESSATION 3 0.0001
373 DELIRIUM 2 0.0001
374 DEVICE USE ISSUE 1 0.0001
375 AMENORRHOEA 1 0.0001
376 HEAD DISCOMFORT 1 0.0001
377 GOUT 1 0.0001
378 GASTROENTERITIS VIRAL 1 0.0001
379 LEUKOCYTOSIS 1 0.0001
380 END STAGE RENAL DISEASE 1 0.0001
381 BLOOD GLUCOSE ABNORMAL 1 0.0001
382 AGRANULOCYTOSIS 1 0.0001
383 NECK PAIN 3 0.0001
384 THINKING ABNORMAL 1 0.0001
385 MIDDLE INSOMNIA 1 0.0001
386 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
387 ASTHMA 6 0.0001
388 INTESTINAL OBSTRUCTION 2 0.0001
389 UNEVALUABLE EVENT 4 0.0001
390 ACNE 4 0.0001
391 HERPES ZOSTER 3 0.0001
392 PULMONARY FIBROSIS 1 0.0001
393 POST PROCEDURAL COMPLICATION 1 0.0001
394 HERNIA 1 0.0001
395 DYSPHONIA 3 0.0001
396 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
397 PARAESTHESIA 8 0.0001
398 HAEMATOCRIT DECREASED 1 0.0001
399 TASTE DISORDER 1 0.0000
400 BONE MARROW FAILURE 1 0.0000
401 INJURY ASSOCIATED WITH DEVICE 1 0.0000
402 BLINDNESS 2 0.0000
403 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
404 PULMONARY HYPERTENSION 1 0.0000
405 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
406 JOINT INJURY 1 0.0000
407 RHINORRHOEA 3 0.0000
408 MENTAL DISORDER 2 0.0000
409 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
410 TOOTH DISORDER 1 0.0000
411 INFLUENZA 5 0.0000
412 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
413 HEPATIC ENZYME INCREASED 3 0.0000
414 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
415 PRODUCT AVAILABILITY ISSUE 1 0.0000
416 TINNITUS 2 0.0000
417 SKIN DISCOLOURATION 2 0.0000
418 HYPOKALAEMIA 2 0.0000
419 PERICARDIAL EFFUSION 1 0.0000
420 PRODUCT PRESCRIBING ERROR 1 0.0000
421 PRESYNCOPE 1 0.0000
422 BRONCHITIS 3 0.0000
423 PYREXIA 14 0.0000
424 PRODUCT COMPLAINT 1 0.0000
425 CARDIOVASCULAR DISORDER 1 0.0000
426 HAEMATOMA 1 0.0000
427 ABDOMINAL DISTENSION 4 0.0000
428 ANHEDONIA 1 0.0000
429 PANCREATITIS 2 0.0000
430 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
431 MOOD ALTERED 1 0.0000
432 MEDICATION ERROR 2 0.0000
433 RENAL IMPAIRMENT 3 0.0000
434 OXYGEN SATURATION DECREASED 2 0.0000
435 INTENTIONAL DOSE OMISSION 1 0.0000
436 CONVULSION 2 0.0000
437 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
438 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
439 SURGERY 2 0.0000
440 NASAL CONGESTION 2 0.0000
441 RENAL INJURY 1 0.0000
442 GASTROINTESTINAL DISORDER 3 0.0000
443 ADVERSE DRUG REACTION 3 0.0000
444 NO ADVERSE EVENT 6 0.0000
445 LACRIMATION INCREASED 1 0.0000
446 EPILEPSY 1 0.0000
447 NASOPHARYNGITIS 6 0.0000
448 LIMB DISCOMFORT 1 0.0000
449 FEMUR FRACTURE 1 0.0000
450 DRUG INTERACTION 5 0.0000
451 MIGRAINE 3 0.0000
452 MOOD SWINGS 1 0.0000
453 CONTUSION 3 0.0000
454 DRUG INTOLERANCE 3 0.0000
455 NIGHT SWEATS 1 0.0000
456 LACTIC ACIDOSIS 1 0.0000
457 PRODUCT DOSE OMISSION 2 0.0000
458 EYE DISORDER 1 0.0000
459 STAPHYLOCOCCAL INFECTION 1 0.0000
460 DEATH 26 0.0000
461 FEBRILE NEUTROPENIA 2 0.0000
462 SKIN DISORDER 1 0.0000
463 NEOPLASM MALIGNANT 2 0.0000
464 ANGER 1 0.0000
465 PRODUCT QUALITY ISSUE 4 0.0000
466 NEUTROPENIA 4 0.0000
467 ABDOMINAL PAIN UPPER 6 0.0000
468 NIGHTMARE 1 0.0000
469 COVID-19 5 0.0000
470 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
471 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
472 THERAPY INTERRUPTED 2 0.0000
473 HYPERGLYCAEMIA 1 0.0000
474 PANIC ATTACK 1 0.0000
475 PRODUCT DOSE OMISSION ISSUE 8 0.0000
476 HEPATIC FUNCTION ABNORMAL 1 0.0000
477 DYSPNOEA EXERTIONAL 1 0.0000
478 CHRONIC KIDNEY DISEASE 2 0.0000
479 SOMNOLENCE 5 0.0000
480 DYSKINESIA 1 0.0000
481 OSTEOPOROSIS 1 0.0000
482 RHABDOMYOLYSIS 1 0.0000
483 WITHDRAWAL SYNDROME 1 0.0000
484 HYPOACUSIS 1 0.0000
485 BALANCE DISORDER 2 0.0000
486 RASH 10 0.0000
487 MUSCULOSKELETAL STIFFNESS 2 0.0000
488 LIVER DISORDER 1 0.0000
489 HEADACHE 14 0.0000
490 THROAT IRRITATION 1 0.0000
491 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
492 CHEST PAIN 4 0.0000
493 WEIGHT DECREASED 6 0.0000
494 VOMITING 10 0.0000
495 DISEASE RECURRENCE 1 0.0000
496 COMA 1 0.0000
497 RASH ERYTHEMATOUS 1 0.0000
498 BLOOD GLUCOSE DECREASED 1 0.0000
499 HYPOGLYCAEMIA 1 0.0000
500 MALAISE 9 0.0000
501 DYSPEPSIA 2 0.0000
502 DIZZINESS 10 0.0000
503 HYPOAESTHESIA 3 0.0000
504 LEUKOPENIA 1 0.0000
505 PAIN 12 0.0000
506 INFLAMMATION 1 0.0000
507 DEPRESSED MOOD 1 0.0000
508 DISTURBANCE IN ATTENTION 1 0.0000
509 RASH PRURITIC 1 0.0000
510 OEDEMA 1 0.0000
511 CONSTIPATION 4 0.0000
512 HAEMATOCHEZIA 1 0.0000
513 ANAPHYLACTIC REACTION 1 0.0000
514 PANCYTOPENIA 1 0.0000
515 WEIGHT INCREASED 4 0.0000
516 BLISTER 1 0.0000
517 FLATULENCE 1 0.0000
518 URINARY TRACT INFECTION 3 0.0000
519 DEPRESSION 4 0.0000
520 LETHARGY 1 0.0000
521 PRODUCT SUBSTITUTION ISSUE 1 0.0000
522 ABDOMINAL PAIN 4 0.0000
523 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
524 IRRITABILITY 1 0.0000
525 JOINT SWELLING 2 0.0000
526 NAUSEA 13 0.0000
527 VERTIGO 1 0.0000
528 EXPOSURE DURING PREGNANCY 1 0.0000
529 SWELLING FACE 1 0.0000
530 ALOPECIA 3 0.0000
531 FALL 5 0.0000
532 DEHYDRATION 2 0.0000
533 HYPOTENSION 3 0.0000
534 VISION BLURRED 2 0.0000
535 FATIGUE 11 0.0000
536 ANXIETY 4 0.0000
537 EPISTAXIS 1 0.0000
538 ASTHENIA 5 0.0000
539 INJECTION SITE SWELLING 1 0.0000
540 PERIPHERAL SWELLING 2 0.0000
541 ARTHRITIS 1 0.0000
542 CARDIAC FAILURE 1 0.0000
543 THROMBOSIS 1 0.0000
544 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
545 DIARRHOEA 8 0.0000
546 CONFUSIONAL STATE 2 0.0000
547 INFLUENZA LIKE ILLNESS 1 0.0000
548 CARDIAC ARREST 1 0.0000
549 DRUG DOSE OMISSION 2 0.0000
550 TREATMENT FAILURE 1 0.0000
551 ARTHRALGIA 5 0.0000
552 MYALGIA 2 0.0000
553 PRODUCT STORAGE ERROR 1 0.0000
554 INSOMNIA 3 0.0000
555 SUICIDAL IDEATION 1 0.0000
556 ADVERSE EVENT 1 0.0000
557 OROPHARYNGEAL PAIN 1 0.0000
558 CARDIAC DISORDER 1 0.0000
559 DRUG INEFFECTIVE 14 0.0000
560 BLOOD GLUCOSE INCREASED 2 0.0000
561 DYSPHAGIA 1 0.0000
562 PULMONARY EMBOLISM 1 0.0000
563 NEUROPATHY PERIPHERAL 1 0.0000
564 ANAEMIA 2 0.0000
565 PRURITUS 4 0.0000
566 HEART RATE INCREASED 1 0.0000
567 SYNCOPE 1 0.0000
568 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
569 HAEMOGLOBIN DECREASED 1 0.0000
570 PLATELET COUNT DECREASED 1 0.0000
571 RHEUMATOID ARTHRITIS 1 0.0000
572 MUSCULAR WEAKNESS 1 0.0000
573 INCORRECT DOSE ADMINISTERED 2 0.0000
574 DECREASED APPETITE 2 0.0000
575 BACK PAIN 2 0.0000
576 DISEASE PROGRESSION 1 0.0000
577 EMOTIONAL DISTRESS 1 0.0000
578 OEDEMA PERIPHERAL 1 0.0000
579 LOSS OF CONSCIOUSNESS 1 0.0000
580 HYPERHIDROSIS 1 0.0000
581 MEMORY IMPAIRMENT 1 0.0000
582 PAIN IN EXTREMITY 2 0.0000
583 BLOOD PRESSURE INCREASED 1 0.0000
584 URTICARIA 1 0.0000
585 ABDOMINAL DISCOMFORT 1 0.0000
586 TOXICITY TO VARIOUS AGENTS 1 0.0000
587 CEREBROVASCULAR ACCIDENT 1 0.0000
588 MYOCARDIAL INFARCTION 1 0.0000
589 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
590 HYPERTENSION 1 0.0000
591 INJECTION SITE PAIN 1 0.0000